TotalMarketCap

HUTCHMED (China)

HCMNasdaq Hong KongHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.477 B

$14.20 +2.01%

Close of 6 Nov 2026

As of 6 Nov 2026, HUTCHMED (China) (HCM) has a market capitalization of $2.48B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$548.5M

#1848 by revenue

Earnings

$456.9M

#649 by earnings

Shares outstanding

872,327,620

Latest filing cover page

P/E ratio

5.4

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #79Arcus BiosciencesRCUS$2.55B
  2. #80Zai LabZLAB$2.54B
  3. #81HUTCHMED (China)HCM$2.48B
  4. #82Palvella TherapeuticsPVLA$2.48B
  5. #83Xeris BiopharmaXERS$2.37B

What if HUTCHMED (China) were worth as much as…

Open the what-if tool →

Gold $28.2T

$161,847.87

Per share 11,398× higher

Bitcoin $1.53T

$8,757.31

Per share 617× higher

Apple $5.02T

$28,749.42

Per share 2,025× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for HUTCHMED (China) are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.